Actemra is biologic therapy that is indicated for treating
- moderately to severely active rheumatoid arthritis (RA) who has had an inadequate response to one or more disease-modifying anti-rheumatic drugs (DMARDs)
- giant cell arteritis (GCA)
- active polyarticular juvenile idiopathic arthritis
- active systemic juvenile idiopathic arthritis
Actemra, also known as tocilizumab, is a biologic infusion therapy indicated to treat rheumatoid arthritis. Ultimately, Actemra reduces inflammation.
Actemra treatments are typically given every two weeks, with each infusion session lasting about 60 minutes.
Patients choose NJ Infusion Services
to have their Actemra therapy because
- of our flexible, worry-free scheduling, with evening and weekend appointments available
- our all-private infusion suites, with the latest COVID safety standards in place for your protection
- equipped with medical-grade, leather recliners, with chairs and amenities for your guests
- including large, flat screen TVs, free WiFi and entertainment channels for your viewing pleasure
- and our friendly, helpful clinical staff providing personalized service
Want to move to
NJ Infusion Services?
We make it simple and convenient for you to start your infusion care with us.
New Patients
